Articles | Open Access | https://doi.org/10.37547/ajbspi/Volume02Issue12-04

SYSTEM MODELING OF PHARMACEUTICAL CARE IN OPHTHALMOLOGICAL PRACTICE AND ORGANIZATIONAL AND ECONOMIC JUSTIFICATION OF THE MAIN DIRECTIONS OF ITS IMPLEMENTATION

Shodmanov Shoyusuf Furkatovich , Competitor of the Tashkent Pharmaceutical Institute, Uzbekistan
Umarova Shakhnoza Ziyatovna , Pharmaceutical Institute of Education and Research, Ph.D. prof., Uzbekistan

Abstract

In order to introduce pharmaceutical care (PC) to ophthalmic patients, we studied the statistics of diseases, conducted an assortment analysis of drugs used in ophthalmic diseases. The analysis of the purchase of drugs was carried out, the index of renewal and consumption of medicines used in ophthalmic practice was considered. Based on the analysis, a AF model has been developed that will improve the effectiveness and safety of drug therapy, as well as improve the quality of life of the patient by integrating the efforts of medical, pharmaceutical specialists and patients.

Keywords

Pharmaceutical care, ophthalmology, medicines

References

N.N. Zubov, V.I. Kuvakin. Methods of multivariate statistical data analysis in medicine and pharmacy. Tutorial. St. Petersburg-2017. –S.138-150.

Belousova O. V., Belousov E. A., Bugaeva A. S. Monitoring the provision of pharmaceutical care to the population of the city of Belgorod // Scientific results of biomedical research

Umarova Sh. Z., Shodmanov Sh. F., Sultanbayeva N. M. U. Development of a system management model for the process of providing pharmaceutical care to patients with diseases of the eye and adnexa // Scientific progress as a key factor in the development of the sphere of knowledge. - 2020. - S. 332-337.

Article Statistics

Copyright License

Download Citations

How to Cite

Shodmanov Shoyusuf Furkatovich, & Umarova Shakhnoza Ziyatovna. (2022). SYSTEM MODELING OF PHARMACEUTICAL CARE IN OPHTHALMOLOGICAL PRACTICE AND ORGANIZATIONAL AND ECONOMIC JUSTIFICATION OF THE MAIN DIRECTIONS OF ITS IMPLEMENTATION. American Journal Of Biomedical Science & Pharmaceutical Innovation, 2(12), 21–26. https://doi.org/10.37547/ajbspi/Volume02Issue12-04